by Brenda Baletti, Ph.D., Childrens Health Defense:

An investigation by Gilead, maker of remdesivir, confirmed the presence of glass, according to the company recall notice posted on the FDA website warning the contaminated vials can cause stroke and “even lead to death.”

Pharmaceutical giant Gilead recalled one batch of its COVID-19 antiviral drug Veklury, the brand name for remdesivir, after glass particles were discovered in vials of the drug, Newsweek reported.